Table: begin end state 1 19 non-cytoplasmic 20 40 transmembrane 41 44 cytoplasmic 45 71 transmembrane 72 107 cytoplasmic 108 133 transmembrane 134 144 non-cytoplasmic 145 187 transmembrane 188 202 non-cytoplasmic 203 223 transmembrane 224 255 cytoplasmic 256 279 transmembrane 280 315 non-cytoplasmic 316 341 transmembrane 342 352 cytoplasmic 353 381 transmembrane 382 386 non-cytoplasmic 387 387 cytoplasmic 388 406 transmembrane 407 416 cytoplasmic 417 443 transmembrane 444 463 non-cytoplasmic 464 487 transmembrane 488 500 cytoplasmic
Input: >RR42_RS15180 MELLANLGLGFSTALTLQNLAYAFLGCVLGTLIGVLPGLGPLATIAMLLPVTYTLPPVAA LIMLAGIYYGAQYGGSTTAILVNLPGESSSVVTTIDGYQMARRGRAGVALATAGLGSFFA GCVATLILAAFAAPLSELAFKFGPAEYFSLMVLGLIGAVVLASGSLVKAIAMIVLGLLLG LVGTDVNSGAARFSFDVPELTDGLNFVSVAMGVFGFAEIIANLEQKDARETFTDHITNLF PTKADFKRMIPAVLRGTFLGSALGILPGGGAALASFAAYSLEKKTSKFSHEFGKGAIEGV AGPESANNAAAQTSFIPLLTLGIPPNAVMALMVGAMTIHNIQPGPQVMTSNPALFWGLIA SMWIGNFMLIILNLPLIGIWVKLLKVPYRYLYPAILVFCCIGVYSVQNTTFDVFQTAAFG VIGYLFIKLKCEPAPLLLGFVLGPMMEENFRRSLLLSRGEFSVFLTRPLSLGLLIAAAVL VLIVALPSIKNKREEAFQEE
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server